180 related articles for article (PubMed ID: 31109948)
21. The Extracellular Domain of the β
Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
[TBL] [Abstract][Full Text] [Related]
22. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
23. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
[TBL] [Abstract][Full Text] [Related]
24. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
25. Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin-2-activated T cells.
Zhou YW; Komada Y; Inaba H; Deguchi T; Sugiyama K; Azuma E; Sakurai M
Immunol Invest; 1998; 27(4-5):309-22. PubMed ID: 9730091
[TBL] [Abstract][Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
27. Solving the riddle: Unraveling the mechanisms of blocking the binding of leukotoxin by therapeutic antagonists in periodontal diseases.
Abdullahi M; Olotu FA; Soliman ME
J Cell Biochem; 2018 Nov; 119(11):9364-9379. PubMed ID: 30129224
[TBL] [Abstract][Full Text] [Related]
28. Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis.
Hiyoshi T; Domon H; Maekawa T; Nagai K; Tamura H; Takahashi N; Yonezawa D; Miyoshi T; Yoshida A; Tabeta K; Terao Y
Microbiol Immunol; 2019 Mar; 63(3-4):100-110. PubMed ID: 30817027
[TBL] [Abstract][Full Text] [Related]
29. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of LtxA (Leukotoxin), a Potent New Anti-Inflammatory Agent for the Treatment of Alopecia Areata.
Kachlany SC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):19-22. PubMed ID: 26551939
[TBL] [Abstract][Full Text] [Related]
31. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
34. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.
Childress C; Feuerbacher LA; Phillips L; Burgum A; Kolodrubetz D
J Bacteriol; 2013 May; 195(10):2284-97. PubMed ID: 23475968
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
36. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
[TBL] [Abstract][Full Text] [Related]
37. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
[TBL] [Abstract][Full Text] [Related]
38. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
[TBL] [Abstract][Full Text] [Related]
39. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
[TBL] [Abstract][Full Text] [Related]
40. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
Johansson A
Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
